Jiatong Li

机构：Shandong University of Traditional Chinese Medicine, Shandong University, Harbin Medical University, Tianjin University, University of Pittsburgh, Capital Medical University, Yantai University, Anhui Medical University, Renji Hospital, Hefei Institutes of Physical Science, Shantou University, Jiading District Central Hospital, Shanghai Cancer Institute, Shantou University Medical College, Peking University Shenzhen Hospital, First Affiliated Hospital of Anhui Medical University, State Key Laboratory of Oncogene and Related Genes, Hearing4all, Third People's Hospital of Hefei, Huashan Hospital, State Key Laboratory of Low-Dimensional Quantum Physics, Tianjin Medical University, Dalian Jiaotong University, China Medical University, Tsinghua University · ORCID：0000-0003-3778-5633

发表论文 218 篇 · 总被引 3242 次 · h-index 31

代表论文

Hui‐Xiang Decoction Against Pancreatic Cancer by Regulating AKT and Activating the Hippo Signaling Pathway (2026 · Chemistry & Biodiversity · 被引 3)
Identification of lncRNAs Indicating Immune Pathway Activity for Predicting Prognosis and Immunotherapy Response in Pan‐Cancer (2026 · Cancer Medicine · 被引 1)
Convergent TBK1 loss of function drives gasdermin E dependent pyroptosis and motor neuron degeneration across ALS genotypes (2026 · Cell Death and Differentiation)
Routine Laboratory Biomarkers for Survival Prediction After Limb-Salvage Surgery in Osteosarcoma: Development of a LASSO-Cox Prognostic Model and Internal Validation (2026 · Journal of Clinical Medicine)
CSF peptidomics reveals an IGF2-derived peptide as a candidate biomarker for neurosyphilis diagnosis (2026 · Frontiers in Microbiology)
Early EASIX and Short-Term Mortality After Acute Myocardial Infarction: A Dual-Cohort Prognostic Study (2026 · Journal of Clinical Medicine)